相关实验视频
Updated: Jun 15, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
麻性低血糖症:最佳临床指导的概述
Nikolaos Nektarios Karamanolis1, Dimitris Kounatidis2, Natalia G Vallianou3
12th Department of Internal Medicine, Medical School, National & Kapodistrian University of Athens, Hippokratio General Hospital, 11527, Athens, Greece.
麻性低血糖症 (NICTH) 是一种罕见的恶性瘤并发症,由瘤分泌胰岛素类生长因子引起. 诊断包括测量IGF-2,治疗可能包括手术,药物或针对IGF-2的新疗法.
科学领域:
- 内分泌学和瘤学的内分泌学和瘤学.
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 副发性低血糖症或非岛屿细胞瘤低血糖症 (NICTH) 是各种恶性瘤的罕见但严重的并发症.
- 它经常与产生胰岛素样生长因子 (IGFs) 的瘤有关,主要是IGF-2及其前体.
- 这些IGF破坏葡萄糖平衡,导致过度使用葡萄糖.
研究的目的:
- 增强对神经瘤性低血糖症的理解,重点关注其病原和诊断方法.
- 为NICTH提供最佳医疗管理的指导.
- 审查IGF-2介导低血糖症的当前和新兴治疗策略.
主要方法:
- 诊断包括记录症状性低血糖症并排除其他原因.
- 关键的诊断工具包括成像研究和实验室测试.
- 特定的实验室测试测量IGF-2水平和IGF-2:IGF-1比率.
主要成果:
- 由于瘤分泌的IGFs,NICTH的特征是低血糖症.
- 诊断确认依赖于临床表现,排除其他原因和特定生物标志物测量.
- 治疗策略各不相同,既针对潜在的瘤,也针对低血糖状态.
结论:
- 为了有效管理NICTH,需要采用综合方法,将诊断和治疗整合起来.
- 手术切除,药理干预 (如皮质类固醇) 和支持性护理是当前治疗的主要支柱.
- 针对IGF-2的新兴疗法,如单克隆抗体和siRNA,提供了有前途的未来治疗途径.
更多相关视频
07:35Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
Published on: January 26, 2024
06:59Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
Published on: November 13, 2016
相关概念视频
Hypoglycemia and Glucagon
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Acute Pancreatitis II: Clinical Manifestations and Management
Oral Hypoglycemic Agents: Glinides
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...